Compare Lustrum:SANTEN PHARMACEUTICAL CO.,LTD.:4536

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index SANTEN PHARMACEUTICAL CO.,LTD. Go to web site 4536 Medicals 東証プライム March 1, 2000 1963.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2023年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2022年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2021年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2020年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Balance Sheet 2019年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Cash and Cash Equivalents
(Percent)
57,903down
(13.7%)down
83,014up
(18.0%)up
62,888down
(15.5%)down
91,430up
(22.4%)up
70,796
(18.1%)
Other Current AssetsHelp
(Percent)
155,423up
(36.9%)up
146,412up
(31.8%)down
143,343up
(35.4%)up
127,126up
(31.1%)down
123,946
(31.7%)
Tangible Fixed AssetsHelp
(Percent)
66,173up
(15.7%)up
56,287up
(12.2%)up
39,489up
(9.7%)up
35,601up
(8.7%)up
31,699
(8.1%)
Intangible Fixed AssetHelp
(Percent)
88,924down
(21.1%)down
116,502up
(25.3%)down
103,104up
(25.4%)up
97,723down
(23.9%)down
108,397
(27.7%)
Investments and OthersHelp
(Percent)
45,371up
(10.8%)up
44,046up
(9.6%)down
43,757up
(10.8%)up
34,761up
(8.5%)down
33,635
(8.6%)
Total AssetsHelp
(Percent)
421,179
(100%)
459,976
(100%)
405,285
(100%)
408,768
(100%)
391,186
(100%)
Total Current LiabilitiesHelp
(Percent)
93,686down
(22.2%)up
100,464up
(21.8%)up
84,963up
(21.0%)up
78,311down
(19.2%)down
96,723
(24.7%)
Total Long-term LiabilitiesHelp
(Percent)
33,513up
(8.0%)up
22,023up
(4.8%)up
10,141down
(2.5%)down
27,592up
(6.8%)up
3,563
(0.9%)
Shareholder's EquityHelp
(Percent)
293,980down
(69.8%)down
337,489up
(73.4%)down
310,181up
(76.5%)up
302,865up
(74.1%)down
290,900
(74.4%)
Total LiabilitiesHelp
(Percent)
421,179
(100%)
459,976
(100%)
405,285
(100%)
408,768
(100%)
391,186
(100%)

SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2023年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2022年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2021年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2020年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Profit and Loss Account 2019年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Amount of Sales
(Percent)
279,037
(100%)
266,257
(100%)
249,605
(100%)
241,555
(100%)
234,026
(100%)
Total Sales
(Percent)
279,037
(100%)
266,257
(100%)
249,605
(100%)
241,555
(100%)
234,026
(100%)
Cost of SalesHelp
(Percent)
112,950up
(40.5%)down
109,671up
(41.2%)up
98,221up
(39.4%)up
94,831up
(39.3%)up
90,764
(38.8%)
Other Costs and RevenueHelp 181,035up
(64.9%)up
129,368down
(48.6%)down
142,073up
(56.9%)up
123,106up
(51.0%)up
111,308
(47.6%)
Total CostsHelp 293,985 239,039 240,294 217,937 202,072
Net RevenueHelp 166,087up
(59.5%)up
156,586up
(58.8%)down
151,384up
(60.6%)down
146,724up
(60.7%)down
143,262
(61.2%)
Earnings Before TaxHelp -5,799down
(-2.1%)down
35,616up
(13.4%)up
11,688down
(4.7%)down
32,091down
(13.3%)down
43,117
(18.4%)
Net IncomeHelp -14,948down
(-5.4%)down
27,218up
(10.2%)up
9,311down
(3.7%)down
23,618down
(9.8%)down
31,954
(13.7%)
当期純利益 -14,948 27,218 9,311 23,618 31,954

SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2023年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2022年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2021年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2020年3月期 SANTEN PHARMACEUTICAL CO.,LTD. Cash Flow Statement 2019年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2023 March 31, 2022 March 31, 2021 March 31, 2020 March 31, 2019
Operating Cash Flow(OFC)Help
(Percent)
37,147down
(58.0%)down
46,043up
(83.3%)up
38,808down
(55.4%)down
39,947up
(100.0%)
32,894
(100.0%)
Investing Cash Flow(ICF)Help
(Percent)
-26,777up
(-41.8%)up
-35,169up
(-63.6%)up
-53,355down
(-76.2%)down
-5,175down
(-13.0%)down
-2,935
(-8.9%)
Financing Cash FlowHelp
(Percent)
-37,220down
(-58.2%)down
5,557up
(10.0%)up
-16,685down
(-23.8%)up
-12,729up
(-31.9%)up
-28,107
(-85.4%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
1,739down
(2.7%)down
3,694up
(6.7%)up
2,690up
(3.8%)up
-1,410down
(-3.5%)down
-338
(-1.0%)
Net Increase and Decrease in Cash and Cash Equivalentsn -25,111down
(-39.2%)down
20,125up
(36.4%)up
-28,542down
(-40.8%)down
20,633up
(51.7%)up
1,514
(4.6%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

SANTEN PHARMACEUTICAL CO.,LTD.

Company where related level is highHelp

RaQualia Pharma Inc.
Takeda Pharmaceutical Company Limited
DENKA SEIKEN Co.,Ltd.
Noile-Immune Biotech Inc.
FunPep Company Limited
KISSEI PHARMACEUTICAL CO.,LTD.
SymBio Pharmaceuticals Limited
LTT Bio-Pharma Co.,Ltd.
Sumitomo Pharma Co., Ltd.
BrightPath Biotherapeutics Co., Ltd.